ArticleAnnals of internal medicine2023

In severe, uncontrolled asthma, tezepelumab reduced exacerbations over 1 y regardless of type 2 inflammation level.

Rodolfo A Estrada et al.PubMed ↗Publisher ↗

No numbers read from the abstract.